Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement

Oxidative Medicine and Cellular Longevity

Volumn 3, Issue 2, 2010, Pages 122-128

  Hamzaoui, Agnès ^a,b   Chelbi, Hanene ^b   Sassi, Fayçal Hai ^b   Hamzaoui, Kamel ^b  

^a ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

B cell activating factor of the TNF family; Beh et's disease; Bronchoalveolar lavage; IL 13; IL 6

Indexed keywords

ABSOLUTE NUMBER; B CELL-ACTIVATING FACTOR OF THE TNF FAMILY; B CELLS; BRONCHIOLITIS; CELL SURVIVAL; CYTOKINES; HEALTHY CONTROLS; PULMONARY ARTERY; VENOUS THROMBOSIS;

BIOLOGICAL ORGANS; CELLS; FLUIDS; PULMONARY DISEASES;

CYTOLOGY;

ALBUMIN; B CELL ACTIVATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 6;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG DISEASE; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL;

ADULT; B-CELL ACTIVATING FACTOR; BEHCET SYNDROME; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-6; LUNG; MALE; MIDDLE AGED;

EID: 77953688927     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.3.2.11149     Document Type: Article

References (33)

1. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335:1078-80.
2. Yazici H, Esen F. Mortality in Behçet's syndrome. Clin Exp Rheumatol 2008; 26:138-40.
3. Uzun O, Erkan L, Akpolat I, et al. Pulmonary involvement in Behçet's disease. Respiration 2008; 75:310-21.
4. Hamzaoui A, Hamzaoui K. Pulmonary complications of Behcet's disease and Takayasu's arteritis. Rev Mal Respir 2005; 22:999-1019.
5. Tavil B, Kuskonmaz B, Kiper N, et al. Pulmonary thromboembolism in childhood: a single-center experience from Turkey. Heart Lung 2009; 38:56-65.
6. Uchiyama M, Nagao T, Hattori A, et al. Pulmonary alveolar proteinosis in a patient with Behcet's disease. Respirology 2009; 14:305-8.
7. Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 2009; 158:155-63.
8. Khan WN. B cell receptor and BAFF receptor signaling regulation of B cell homeostasis. J Immunol 2009; 183:3561-7.
9. Gould HJ, Takhar P, Harries HE, et al. Germinal-centre reactions in allergic inflammation, Trends Immunol 2006; 27:446-52.
10. Kim YH, Choi BH, Cheon HG, et al. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp Mol Med 2009; 41:208-16.
11. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009; 9:491-502.
12. Krystufková O, Vallerskog T, Helmers SB, et al. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis 2009; 68:836-43.
13. Kato A, Peters A, Suh L, et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2008; 121:1385-92.
14. Hamzaoui K, Houman H, Ben Dhifallah I, et al. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease. Clin Exp Rheumatol 2008; 26:64-71.
15. Aridogan BC, Yildirim M, Baysal V, et al. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFNgamma in Behçet's disease. J Dermatol 2003; 30:602-7.
16. Akman-Demir G, Tüzün E, Içöz S, et al. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome. Cytokine 2008; 44:373-6.
17. Adam BE. Calikoglu, Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease. J Eur Acad Dermatol Venereol 2004; 18:318-20.
18. Hamzaoui K, Hentati F, Hamzaoui A. BAFF is upregulated in central nervous system of neuro-Behçet's disease. J Neuroimmunol 2008; 200:111-4.
19. Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009; 21:612-8.
20. Cash H, Relle M, Menke J, et al. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol 2010; 37:60-70.
21. Adam B, Calikoglu E. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease. J Eur Acad Dermatol Venereol 2004; 18:318-20.
22. Mege L, Dilsen N, Sanguedolce V, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993; 20:1544-9.
23. Raziuddin S, al-Dalaan A, Bahabri S, et al. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 1998; 25:329-33.
24. Dinç A, Karaayvaz M, Caliskaner AZ, et al. Dermographism and atopy in patients with Behçet's disease. J Investig Allergol Clin Immunol 2000; 10:368-71.
25. Akman-Demir G, Tüzün E, Içöz S, et al. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome. Cytokine 2008; 44:373-6.
26. Hamzaoui K, Hamzaoui A, Guemira F, et al. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002; 31:205-10. (Pubitemid 34971876)
27. Evereklioglu C, Er H, Türköz Y, et al. Serum levels of TNFalpha, sIL-2R, IL-6 and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Mediators Inflamm 2002; 11:87-93. (Pubitemid 34526411)
28. Kalpaklioglu AF, Gürbüz L, Gürler A, et al. Bronchial hyperreactivity and immunoglobulin E in Behçet's disease. Allergol Immunopathol 1997; 25:182-8. (Pubitemid 127517440)
29. Huard B, Arlettaz L, Ambrose C, et al. BAFF production by antigen-presenting cells provides T cell costimulation. Int Immunol 2004; 16:467-75. (Pubitemid 38313155)
30. Darce JR, Arendt BK, Chang SK, et al. Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J Immunol 2007; 178:5612-22.
31. Kato A, Xiao H, Chustz RT, et al. Local release of B cell-activating factor of the TNF family after segmental allergen challenge of allergic subjects. J Allergy Clin Immunol 2009; 123:369-75.
32. + T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol 2009; 182:793-801.
33. Hamzaoui A, Ghraïri H, Ammar J, et al. IL-18 mRNA expression and IFNγ induction in bronchoalveolar lavage from Behçet's disease. Clin Expe Rheumatol 2003; 21:8-14.